Dissemination (Meeting Coverage)

Adjuvant therapy with atezolizumab and bevacizumab improved recurrence-free survival in patients...

In MS, a lower cortical imbalance between excitation and inhibition may serve as a predictive...

It is recommended that neurologists discuss the benefits of improving diet quality with their...

Although new immunotherapies have been used, hepatocellular carcinoma (HCC) still presents a low...

In the IMbrave050 study, the combination of adjuvant atezo (atezolizumab) and bev (bevacizumab)...

In recent years, significant progress has been made in treating advanced unresectable...

Many researchers determined that the clinical significance of circulating tumor DNA (ctDNA) in...

Tislelizumab (TIS) is a specific monoclonal antibody targeting programmed cell death protein 1...

Recurrent cases of non-small cell lung cancer (NSCLC) following surgery are common and carry...

In recent decades, persistent disparities in the survival of individuals with early-stage...

Blood-based methods utilizing circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) are...

For treating non-small cell lung cancer (NSCLC), liquid biopsy (LB) was analyzed using...

Surgical resection is the preferred treatment for early-stage non-small cell lung cancer (NSCLC),...

Frequent falls and the fear of falling (FOF) are significant challenges experienced by individuals...

Researchers conducted a study to examine the effects of mindfulness-based stress reduction (MBSR)...

Fatigue is a common and debilitating symptom among individuals with multiple sclerosis (MS)....

Tolebrutinib, a covalent inhibitor of Bruton tyrosine kinase (BTK), has been specifically...

Tolebrutinib, a potent inhibitor of Bruton tyrosine kinase that can cross the blood-brain barrier,...

A registry data analysis concluded that most disease-modifying therapies for MS are not associated...

The VISIONARY-MS trial showed that CNM-Au8, an oral liquid suspension of gold nanoparticles,...